Hemodynamic Monitoring Technologies in Advanced Heart Failure

doi:N/A

Bangaldesh Journal of Cardivascular Medicine

2025, Volume 3, Issue 2 : 1-4

Research Article

Hemodynamic Monitoring Technologies in Advanced Heart Failure

Michael R. Anderson

Sarah T. Bennett

Ahmed K. Rahman

Priya Sharma

⁴

David L. Cooper

⁵

Heart Institute of North America, Chicago, USA

Royal Cardiovascular Centre, London, UK

International Medical Research University, Dubai, UAE

⁴

South Asian Heart Institute, New Delhi, India

⁵

Global Cardiovascular Sciences Center, Toronto, Canada

Abstract

Background: Advanced heart failure is associated with recurrent congestion, hospitalization, reduced quality of life, and high mortality. Hemodynamic monitoring technologies help detect worsening filling pressures before symptoms become severe.

Objective: To review invasive, implantable, wearable, and non-invasive hemodynamic monitoring technologies used in advanced heart failure and evaluate their clinical utility, outcomes, and safety.

Methods: This narrative review summarizes contemporary evidence, device principles, patient selection, clinical workflows, benefits, limitations, and future directions of hemodynamic monitoring in advanced heart failure.

Results: Pulmonary artery pressure monitoring, remote device-based diagnostics, echocardiography, right heart catheterization, bioimpedance, wearable sensors, and artificial intelligence–assisted platforms can improve congestion detection and guide therapy. Implantable pulmonary artery pressure sensors have shown reductions in heart failure hospitalization in selected patients.

Conclusion: Hemodynamic monitoring is increasingly central to advanced heart failure management. The greatest benefit occurs when monitoring data are integrated into structured clinical response pathways.

Keywords

Advanced heart failure

Hemodynamic monitoring

Pulmonary artery pressure

CardioMEMS

Remote monitoring

Congestion.

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Bangladesh J. Cardiovasc. Med. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Drug-Coated Balloons in Peripheral Vascular Interventions

Michael R. Anderson,

Sarah T. Bennett,

Ahmed K. Rahman,

Priya Sharma,

David L. Cooper

1-6

Pharmacological Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention

Rahim Uddin,

Nusrat Karim,

Farhana Islam,